Position in ACAD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$15,329,326
-$2,862,908 QoQ
Shares Held
688,649
+1.1% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 11.533161305686932.ToString("F0")%
Shared 0.ToString("F0")%
None 88.46683869431307.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PANAGORA ASSET MANAGEMENT INC holds $504,243,073 across 65 Biotechnology names. ACAD ranks #9 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,210,909 | $113,970,755 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105,225 | $81,301,044 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
742,117 | $55,109,608 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
461,193 | $28,916,801 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
143,499 | $27,128,485 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
351,370 | $23,938,838 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
592,912 | $17,615,415 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
57,320 | $17,022,320 |
All Filings in ACAD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,329,326 | 688,649 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $18,192,234 | 681,102 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,016,816 | 656,833 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,110,964 | 654,194 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,858,936 | 653,759 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,021,837 | 655,141 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,199,585 | 663,172 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,755,387 | 661,870 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $12,966,889 | 701,292 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $20,192,445 | 644,920 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $13,400,078 | 642,998 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $16,170,105 | 675,161 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $13,700,978 | 728,001 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,835,231 | 680,605 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,755,783 | 657,444 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,112,947 | 646,767 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,622,742 | 479,882 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $9,350,424 | 400,618 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,793,921 | 409,026 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $9,910,315 | 406,327 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $118,576 | 4,596 | Shares | Sole | 2021-05-12 | |
| 2020-06-30 | $170,711 | 3,522 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,162,128 | 27,506 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||